داروسازی تهران دارو
دتهران | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: 248
Income Statement
AGM
Interim
2026/08/31 Fiscal Year 2026/03/2012 Month | 2025/10/05 Fiscal Year 2025/03/2012 Month | 2024/10/06 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 21.552 Trillion | 12.647 Trillion | 9.977 Trillion | |
Total Revenues | 21.552 Trillion | 12.647 Trillion | 9.977 Trillion | |
Cost of Goods Sold | 10.47 Trillion | 7.906 Trillion | 5.919 Trillion | |
Gross Profit | 11.081 Trillion | 4.741 Trillion | 4.058 Trillion | |
General & Administrative Expenses | 941.259 Billion | 639.705 Billion | 494.377 Billion | |
Net Operating Income & Expenses | -12.612 Billion | -91 Million | -827 Million | |
Operating Profit (Loss) | 10.128 Trillion | 4.102 Trillion | 3.562 Trillion | |
Profit Before Tax | 8.816 Trillion | 3.013 Trillion | 2.403 Trillion | |
Tax | 1.655 Trillion | 465.401 Billion | 210.378 Billion | |
Net Profit (Loss) After Tax | 7.162 Trillion | 2.547 Trillion | 2.192 Trillion | |
Retained Earnings at Beginning of Period | 4.889 Trillion | 2.583 Trillion | 1.946 Trillion | |
Approved Dividends — Prior Year AGM | -257.6 Billion | -220.8 Billion | -145.8 Billion | |
Capital Decrease (Increase) from Accumulated Losses (Retained Earnings) | - | - | -1.3 Trillion | |
Allocable Profit | 11.793 Trillion | 4.909 Trillion | 2.692 Trillion | |
Legal Reserve | - | 20.381 Billion | 109.619 Billion | |
Approved Dividends — Current Year | 736 Billion | 257.6 Billion | 220.8 Billion | |
Retained Earnings at End of Period | 11.057 Trillion | 4.631 Trillion | 2.362 Trillion |